Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global biologics market reached a value of US$ 294 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 501.9 Billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Biologics Market Trends:

The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biologics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on source, product, disease and manufacturing.

Breakup by Source:

 

 
 

www.imarcgroup.com

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Microbial
  • Mammalian
  • Others
     

Breakup by Product:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others
     

Breakup by Disease:

  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others
     

Breakup by Manufacturing:

  • Outsourced
  • In-House
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Source, Product, Disease, Manufacturing, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Biologics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Source
    6.1    Microbial
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Mammalian
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Product
    7.1    Monoclonal Antibodies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Vaccines
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Recombinant Proteins
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Antisense, RNAi and Molecular Therapy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Disease
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Immunological Disorders
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Cardiovascular Disorders
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Hematological Disorders
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Manufacturing
    9.1    Outsourced
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    In-House
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 SWOT Analysis
        15.3.5    GlaxoSmithKline plc
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Johnson & Johnson
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Novartis AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Pfizer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanofi
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Biologics Market: Major Drivers and Challenges
Figure 2: Global: Biologics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biologics Market: Breakup by Source (in %), 2021
Figure 5: Global: Biologics Market: Breakup by Product (in %), 2021
Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2021
Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2021
Figure 8: Global: Biologics Market: Breakup by Region (in %), 2021
Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Biologics Industry: SWOT Analysis
Figure 89: Global: Biologics Industry: Value Chain Analysis
Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biologics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million US$), 2022-2027
Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million US$), 2022-2027
Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Biologics Market: Competitive Structure
Table 8: Global: Biologics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global biologics market was valued at US$ 294 Billion in 2021.

We expect the global biologics market to exhibit a CAGR of 9.25% during 2022-2027.

The increasing incidences of several chronic diseases, such as Crohn’s disease, ulcerative colitis,
rheumatoid arthritis, etc., that require advanced treatment drugs, are primarily catalyzing the global
biologics market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing need for biologics in the
development of novel vaccine against coronavirus infection, as they control the production of vital
proteins, modify human hormones and cells, while producing substances to maintain the immune
system.

Based on the source, the global biologics market has been segmented into microbial, mammalian, and
others. Among these, microbial holds the majority of the total market share.

Based on the product, the global biologics market can be divided into monoclonal antibodies, vaccines,
recombinant proteins, antisense, RNAi and molecular therapy, and others. Currently, monoclonal
antibodies exhibit a clear dominance in the market.

Based on the disease, the global biologics market has been categorized into oncology, immunological
disorders, cardiovascular disorders, hematological disorders, and others. Among these, oncology
currently accounts for the majority of the global market share.

Based on the manufacturing, the global biologics market can be segregated into outsourced and in-
house. Currently, in-house holds the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global biologics market include AbbVie Inc., Amgen Inc., AstraZeneca
plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer
Inc., and Sanofi.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4